Submit an online request for an in-person or remote consult.
Memorial Sloan Kettering’s international patients receive personalized support from a team of compassionate, knowledgeable staff.
Who You’ll Meet
International Care Advisors: Your international care advisor is your first point of contact at MSK. He or she will help you assemble the necessary medical information and get you set up with the services you have requested.
International Patient Liaisons: Should you choose to come to MSK for care, your International Patient Liaison will be with you every step of the way to ensure your experience is as seamless and convenient as possible. As your main point of contact, your International Patient Liaison can assist with travel arrangements, scheduling treatment and connecting you with resources to make sure your questions are answered timely and efficiently. Your International Patient Liaison will accompany you to some of your outpatient and inpatient visits to ensure you have support throughout your journey at MSK.
Patient Financial Counselors: your counselor will help guide you through the financial component of your healthcare journey at MSK. They are available to answer your questions regarding cost of care, billing, insurance, payments and our financial policy.
Other members of your team at the Bobst International Center include nurse practitioners, nurse case managers, and some of the most renowned cancer experts in the world.
Learn more about the Bobst International Center Leadership Team
Sir Murray F. Brennan
Sir Murray F. Brennan is an oncologic surgeon and scientist. He helps personally guide the care of international patients. He was Chair of the Department of Surgery at Memorial Sloan Kettering from 1985 to 2006. He is currently Senior Vice President of International Programs. Dr. Brennan has lectured throughout the world and authored or co-authored more than 1,100 scientific papers and book chapters, along with three books on soft tissue sarcoma. He has received many honors throughout his career, among them an appointment as Knight Grand Companion of the New Zealand Order of Merit by Queen Elizabeth II.
Bob T. Li, MD, MPH, FRACP
Bob Li is a medical oncologist and physician-scientist who specializes in lung cancers and early-phase drug development for solid tumors. He is also Co-Director of MSK’s multidisciplinary Thoracic Liquid Biopsy Program investigating the use of plasma biomarkers to optimize precision cancer therapy. His translational research in molecular oncology basket trials has transformed national clinical practice guidelines, for which he has received awards from the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Li is an Australian who speaks fluent Chinese Mandarin and is Fellow of the Royal Australasian College of Physicians. As MSK’s Physician Ambassador to China and Asia-Pacific, he represents MSK on an official level and provides leadership in international patient care, research and education programs with China and the Asia-Pacific region. He works closely with colleagues at the International Center and hospital administration to advance MSK’s mission abroad with transparency and impact. Through compassionate care and international partnerships, his career is dedicated to winning the global war on cancer and bringing real hope to patients.
Mrinal Gounder, MD
Mrinal Gounder is an internationally recognized medical oncologist who holds dual appointments in sarcoma and early drug development (phase 1) programs at Memorial Sloan Kettering Cancer Center (MSK). Dr. Gounder specializes in developing new cancer therapies, with a specific focus on sarcoma, a rare cancer that affects children, adolescents, and adults. He joined MSK in 2008 and has a special interest in personalized medicine, a field that uses genetic testing to guide therapy selection, based on an individual patient’s genetic profile.
Dr. Gounder is the principal investigator of several global clinical trials (phase 1 to phase 3) evaluating promising new drugs for sarcoma, among other solid cancers. He was the global lead for the study that led to FDA approval of tazemetostat in sarcoma. In 2018, the American Society of Clinical Oncology recognized Dr. Gounder’s drug development efforts in the setting of rare cancers as one of the Top 10 Advances of the Year in the field of oncology. His original research has been published in The New England Journal of Medicine, the Journal of Clinical Oncology, Lancet Oncology, Nature Medicine, and other medical oncology journals.
He is also MSK’s Physician Ambassador to India and Asia and represents MSK in leadership, research, and educational activities involving India and Asia. In this role, Dr. Gounder — who is fluent in Tamil and Hindi — also works closely with leadership at the Bobst International Center to bring MSK-quality care to these specific areas. He is passionate not only about providing the best treatment options to our international community but also about establishing partnerships to improve access to patient care while fostering global collaborations in education and graduate medical training to advance cancer research and clinical trials.
Email us at [email protected].
Call 212-639-4900, Mon–Fri, 7:00am–5:00pm, ET.
Or use AT&T Direct Access by dialing the access number for the country you are calling from, then dialing 888-675-7722. If you need a translator, we will locate one while you are on the line. Or email [email protected] and tell us the language you speak along with the time you wish to call. We will arrange for a translator to be available.
Bobst International Center
160 East 53rd Street
Rockefeller Outpatient Pavilion, 11th floor
New York, NY 10022